RNA Platform
Levostar Biotech offers a fully integrated RNA production platform designed to meet the evolving needs of customers at every stage of development. From sequence to RNA, our end-to-end solutions ensure top-tier quality control throughout the process. Leveraging cutting-edge technologies—including mRNA, circular RNA, and self-amplifying RNA synthesis—seamlessly integrated with LNP delivery systems, ensuring top-tier quality control, optimal performance, and continuous innovation at every step.
Comparison of different IVT RNA payload formats
| mRNA | Circular RNA | Self-Amplifying RNA | |
| Structure | Linear; Open 5’ and 3’ end mRNA exonuclease degradation | Close loop; No free 5’ 3’ end Eliminating mRNA exonuclease degradation | Linear; Open 5’ and 3’ end mRNA exonuclease degradation |
| Ribosome recruiting | 5’ Cap | Internal Ribosome Entry Site (IRES) | 5’ Cap |
| UTR | Regulatory elements in the 5' and 3' UTR stabilize mRNA and enhance translation initiation | Include IRES + PIE + other elements | Replicon for further self-replication of the mRNA |
| ORF | Insert < 10 kb | Insert < 3 kb | Insert < 6 kb |
| polyA tail | Stabilizes RNA molecule & Prevents degradation | Not required | Stabilizes RNA molecule & Prevents degradation |
| Immunogenicity | Low | Medium | High |
| Protein Expression | Strong | Stronger | Strongest |
| Expression half-life | Short | Longer | Longest |
| Dosage requirement | High | Medium | Low |
Resource
Learn about Levostar’s end-to-end LNP encapsulation platform, from sequence design and RNA production to scalable encapsulation, nanoparticle characterization, and final product delivery.
LNP Encapsulation
LNP Encapsulation
Get in Touch with Levostar
Please send us your request or email to support@levostar.com, our team will contact you as soon as possible.